Skip to main content
SpringerLink
Log in

Staging and Diagnosis of Lung Cancer

  • Chapter
  • First Online:
Lung Cancer

Part of the book series: Respiratory Medicine ((RM))

  • 426 Accesses

Abstract

Appropriate staging of lung cancer using the TNM classification creates a universal language for medical providers when describing lung cancer. Multiple international societies have adopted the recently updated guidelines by the International Association for the Study of Lung Cancer and provide a framework for clinicians. Staging is essential in helping dictate treatment in a particular patient. The staging process begins with a history and physical, a computerized tomography (CT) scan, and, frequently, a positron emission tomography (PET) scan. Invasive staging is required for patients at higher risk of nodal disease, including those with large or central tumors and those with lymphadenopathy. Tissue sampling for staging and diagnosis can be done using endosonography, mediastinoscopy, and/or surgery; each method has limitations in accessing lymph nodes and peripheral nodules with the goal of obtaining enough tissue for staging, diagnosis, and molecular testing as indicated. In patients who undergo surgical resection, final pathological staging supersedes clinical staging.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. O’Neil ME, Henley SJ, Rohan EA, Ellington TD, Gallaway MS. Lung cancer incidence in nonmetropolitan and metropolitan counties—United States, 2007-2016. MMWR Morb Mortal Wkly Rep. 2019;68(44):993–8.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Toumazis I, Bastani M, Han SS, Plevritis SK. Risk-based lung cancer screening: a systematic review. Lung cancer. 2020;147:154–86.

    Article  PubMed  Google Scholar 

  3. Tanoue LT. Lung cancer staging. Clin Chest Med. 2020;41(2):161–74.

    Article  PubMed  Google Scholar 

  4. Mountain CF, Carr DT, Anderson WA. A system for the clinical staging of lung cancer. Am J Roentgenol. 1974;120(1):130–8.

    Article  CAS  Google Scholar 

  5. Ganti AKP, Loo BW, Bassetti M, Blakely C, Chiang A, D’Amico TA, et al. Small cell lung cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2021;19(12):1441–64.

    Article  CAS  Google Scholar 

  6. Amin M. Part VII Thorax. AJCC Cancer Staging Manual (8th ed.). American College of Surgeons. (2017). https://www.r2library.com/Resource/Title/3319406175/pt0007.

  7. Rami-Porta R, Bolejack V, Giroux DJ, Chansky K, Crowley J, Asamura H, et al. The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2014;9(11):1618–24.

    Article  CAS  PubMed  Google Scholar 

  8. Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth edition lung cancer stage classification. Chest. 2017;151(1):193–203.

    Article  PubMed  Google Scholar 

  9. Silvestri GA, Gonzalez AV, Jantz MA, Margolis ML, Gould MK, Tanoue LT, et al. Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e211S–e50S.

    Article  PubMed  Google Scholar 

  10. Rami-Porta R, Call S, Dooms C, Obiols C, Sanchez M, Travis WD, et al. Lung cancer staging: a concise update. Eur Respir J. 2018;51(5):1800190.

    Article  PubMed  Google Scholar 

  11. Rusch VW, Asamura H, Watanabe H, Giroux DJ, Rami-Porta R, Goldstraw P, et al. The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol. 2009;4(5):568–77.

    Article  PubMed  Google Scholar 

  12. Libshitz HI, McKenna RJ Jr, Mountain CF. Patterns of mediastinal metastases in bronchogenic carcinoma. Chest. 1986;90(2):229–32.

    Article  CAS  PubMed  Google Scholar 

  13. Watanabe Y, Shimizu J, Tsubota M, Iwa T. Mediastinal spread of metastatic lymph nodes in bronchogenic carcinoma. Mediastinal nodal metastases in lung cancer. Chest. 1990;97(5):1059–65.

    Article  CAS  PubMed  Google Scholar 

  14. Feng SH, Yang ST. The new 8th TNM staging system of lung cancer and its potential imaging interpretation pitfalls and limitations with CT image demonstrations. Diagn Interv Radiol. 2019;25(4):270–9.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Almeida FA, Uzbeck M, Ost D. Initial evaluation of the nonsmall cell lung cancer patient: diagnosis and staging. Curr Opin Pulm Med. 2010;16(4):307–14.

    Article  PubMed  Google Scholar 

  16. van Meerbeeck JP, Fennell DA, De Ruysscher DK. Small-cell lung cancer. Lancet. 2011;378(9804):1741–55. https://doi.org/10.1016/S0140-6736(11)60165-7.

    Article  PubMed  Google Scholar 

  17. Marshall T, Kalanjeri S, Almeida FA. Lung cancer staging, the established role of bronchoscopy. Curr Opin Pulm Med. 2022;28(1):17–30.

    Article  CAS  PubMed  Google Scholar 

  18. Prenzel KL, Monig SP, Sinning JM, Baldus SE, Brochhagen HG, Schneider PM, et al. Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest. 2003;123(2):463–7.

    Article  PubMed  Google Scholar 

  19. Boland GW, Dwamena BA, Jagtiani Sangwaiya M, Goehler AG, Blake MA, Hahn PF, et al. Characterization of adrenal masses by using FDG PET: a systematic review and meta-analysis of diagnostic test performance. Radiology. 2011;259(1):117–26.

    Article  PubMed  Google Scholar 

  20. Paesmans M, Garcia C, Wong CY, Patz EF Jr, Komaki R, Eschmann S, et al. Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data. Eur Respir J. 2015;46(6):1751–61.

    Article  CAS  PubMed  Google Scholar 

  21. Lv YL, Yuan DM, Wang K, Miao XH, Qian Q, Wei SZ, et al. Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer: a bivariate systematic review and meta-analysis. J Thorac Oncol. 2011;6(8):1350–8.

    Article  PubMed  Google Scholar 

  22. Wu LM, Xu JR, Gu HY, Hua J, Chen J, Zhang W, et al. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better? J Surg Res. 2012;178(1):304–14.

    Article  PubMed  Google Scholar 

  23. Sommer G, Wiese M, Winter L, Lenz C, Klarhofer M, Forrer F, et al. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography. Eur Radiol. 2012;22(12):2859–67.

    Article  PubMed  Google Scholar 

  24. Pauls S, Schmidt SA, Juchems MS, Klass O, Luster M, Reske SN, et al. Diffusion-weighted MR imaging in comparison to integrated [(1)(8)F]-FDG PET/CT for N-staging in patients with lung cancer. Eur J Radiol. 2012;81(1):178–82.

    Article  PubMed  Google Scholar 

  25. Lynch TJ, Bell DW, Sordella R, et al. Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med. 2004;350:2129–39.

    Article  CAS  PubMed  Google Scholar 

  26. Shaw AT, Kim DW, Nakagawa K, et al. Crizotinib versus chemotherapy in advanced ALK-positive lung cancer. N Engl J Med. 2013;368:2285–394.

    Article  Google Scholar 

  27. Rivera MP, Mehta AC, Wahidi MM. Establishing the diagnosis of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e142S–65S.

    Article  PubMed  Google Scholar 

  28. (NCCN) NCCN. NCCN Practice Guide- lines in Oncology. Non Small Cell Lung Cancer Version 5.2021. https://www.Nccn.Org/Professionals/Physician_gls/Pdf/Nscl.Pdf. Accessed 30 Aug 2022.

  29. De Leyn P, Dooms C, Kuzdzal J, Lardinois D, Passlick B, Rami-Porta R, et al. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer. Eur J Cardiothorac Surg. 2014;45(5):787–98.

    Article  PubMed  Google Scholar 

  30. Vansteenkiste J, Crino L, Dooms C, Douillard JY, Faivre-Finn C, Lim E, et al. 2nd ESMO consensus conference on lung cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up. Ann Oncol. 2014;25(8):1462–74.

    Article  CAS  PubMed  Google Scholar 

  31. Detterbeck FC, Lewis SZ, Diekemper R, Addrizzo-Harris D, Alberts WM. Executive summary: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):7S–37S.

    Article  CAS  PubMed  Google Scholar 

  32. Wang KP, Terry P, Marsh B. Bronchoscopic needle aspiration biopsy of paratracheal tumors. Am Rev Respir Dis. 1978;118(1):17–21.

    CAS  PubMed  Google Scholar 

  33. Holty JE, Kuschner WG, Gould MK. Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax. 2005;60(11):949–55.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Detterbeck FC, Jantz MA, Wallace M, Vansteenkiste J, Silvestri GA, American College of Chest P. Invasive mediastinal staging of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). Chest. 2007;132(3 Suppl):202S–20S.

    Article  PubMed  Google Scholar 

  35. Adams K, Shah PL, Edmonds L, Lim E. Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis. Thorax. 2009;64(9):757–62.

    Article  CAS  PubMed  Google Scholar 

  36. Gu P, Zhao YZ, Jiang LY, Zhang W, Xin Y, Han BH. Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis. Eur J Cancer. 2009;45(8):1389–96.

    Article  PubMed  Google Scholar 

  37. Block MI. Endobronchial ultrasound for lung cancer staging: how many stations should be sampled? Ann Thorac Surg. 2010;89(5):1582–7.

    Article  PubMed  Google Scholar 

  38. Lee HS, Lee GK, Lee HS, Kim MS, Lee JM, Kim HY, et al. Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest. 2008;134(2):368–74.

    Article  PubMed  Google Scholar 

  39. Yarmus L, Akulian J, Gilbert C, Feller-Kopman D, Lee HJ, Zarogoulidis P, et al. Optimizing endobronchial ultrasound for molecular analysis. How many passes are needed? Ann Am Thorac Soc. 2013;10(6):636–43.

    Article  PubMed  Google Scholar 

  40. Labarca G, Folch E, Jantz M, Mehta HJ, Majid A, Fernandez-Bussy S. Adequacy of samples obtained by endobronchial ultrasound with transbronchial needle aspiration for molecular analysis in patients with non-small cell lung cancer. Systematic review and meta-analysis. Ann Am Thorac Soc. 2018;15(10):1205–16.

    Article  PubMed  Google Scholar 

  41. Cheng G, Mahajan A, Oh S, Benzaquen S, Chen A. Endobronchial ultrasound-guided intranodal forceps biopsy (EBUS-IFB)-technical review. J Thorac Dis. 2019;11(9):4049–58.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Yasufuku K, Pierre A, Darling G, de Perrot M, Waddell T, Johnston M, et al. A prospective controlled trial of endobronchial ultrasound-guided transbronchial needle aspiration compared with mediastinoscopy for mediastinal lymph node staging of lung cancer. J Thorac Cardiovasc Surg. 2011;142(6):1393–400.e1.

    Article  PubMed  Google Scholar 

  43. Yarmus LB, Akulian JA, Gilbert C, Mathai SC, Sathiyamoorthy S, Sahetya S, et al. Comparison of moderate versus deep sedation for endobronchial ultrasound transbronchial needle aspiration. Ann Am Thorac Soc. 2013;10(2):121–6.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Cornelissen CG, Dapper J, Dreher M, Muller T. Endobronchial ultrasound-guided transbronchial needle aspiration under general anesthesia versus bronchoscopist-directed deep sedation: a retrospective analysis. Endosc Ultrasound. 2019;8(3):204–8.

    Article  PubMed  PubMed Central  Google Scholar 

  45. Casal RF, Lazarus DR, Kuhl K, Nogueras-Gonzalez G, Perusich S, Green LK, et al. Randomized trial of endobronchial ultrasound-guided transbronchial needle aspiration under general anesthesia versus moderate sedation. Am J Respir Crit Care Med. 2015;191(7):796–803.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Fernandes MGO, Santos VF, Martins N, Sucena MC, Passos MM, Marques MM, et al. Endobronchial ultrasound under moderate sedation versus general anesthesia. J Clin Med. 2018;7(11):421.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Chandra S, Chandra H, Sindhwani G. Role of rapid on-site evaluation with cyto-histopathological correlation in diagnosis of lung lesion. J Cytol. 2014;31(4):189–93.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Madan K, Dhungana A, Mohan A, Hadda V, Jain D, Arava S, et al. Conventional transbronchial needle aspiration versus endobronchial ultrasound-guided transbronchial needle aspiration, with or without rapid on-site evaluation, for the diagnosis of sarcoidosis: a randomized controlled trial. J Bronchology Interv Pulmonol. 2017;24(1):48–58.

    Article  PubMed  Google Scholar 

  49. Schacht MJ, Toustrup CB, Madsen LB, Martiny MS, Larsen BB, Simonsen JT. Endobronchial ultrasound-guided transbronchial needle aspiration: performance of biomedical scientists on rapid on-site evaluation and preliminary diagnosis. Cytopathology. 2016;27(5):344–50.

    Article  CAS  PubMed  Google Scholar 

  50. Li C, Sun W-W, Feng J, Cao J, Zhang P. Utilization of rapid on-site evaluation (ROSE) in transbronchial needle aspiration (TBNA), it is not a simple statistical issue. Int J Clin Exp Med. 2016;9:13298.

    Google Scholar 

  51. Simon M, Pop B, Toma IL, Vallasek AK, Simon I. The use of EBUS-TBNA and ROSE in the diagnosis of lung cancer. Romanian J Morphol Embryol. 2017;58(1):79–87.

    Google Scholar 

  52. Caupena C, Esteban L, Jaen A, Barreiro B, Albero R, Perez-Ochoa F, et al. Concordance between rapid on-site evaluation and final cytologic diagnosis in patients undergoing endobronchial ultrasound-guided transbronchial needle aspiration for non-small cell lung cancer staging. Am J Clin Pathol. 2020;153(2):190–7.

    PubMed  Google Scholar 

  53. Liberman M, Duranceau A, Grunenwald E, Martin J, Thiffault V, Khereba M, et al. New technique performed by using EUS access for biopsy of para-aortic (station 6) mediastinal lymph nodes without traversing the aorta (with video). Gastrointest Endosc. 2011;73(5):1048–51.

    Article  PubMed  Google Scholar 

  54. Liberman M, Duranceau A, Grunenwald E, Thiffault V, Khereba M, Ferraro P. Initial experience with a new technique of endoscopic and ultrasonographic access for biopsy of para-aortic (station 6) mediastinal lymph nodes without traversing the aorta. J Thorac Cardiovasc Surg. 2012;144(4):787–92; discussion 92–3.

    Article  PubMed  Google Scholar 

  55. Singh P, Camazine B, Jadhav Y, Gupta R, Mukhopadhyay P, Khan A, et al. Endoscopic ultrasound as a first test for diagnosis and staging of lung cancer: a prospective study. Am J Respir Crit Care Med. 2007;175(4):345–54.

    Article  PubMed  Google Scholar 

  56. Annema JT, Versteegh MI, Veselic M, Voigt P, Rabe KF. Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of lung cancer and its impact on surgical staging. J Clin Oncol Off J Am Soc Clin Oncol. 2005;23(33):8357–61.

    Article  Google Scholar 

  57. Herth FJ, Rabe KF, Gasparini S, Annema JT. Transbronchial and transoesophageal (ultrasound-guided) needle aspirations for the analysis of mediastinal lesions. Eur Respir J. 2006;28(6):1264–75.

    Article  CAS  PubMed  Google Scholar 

  58. Tournoy KG, Praet MM, Van Maele G, Van Meerbeeck JP. Esophageal endoscopic ultrasound with fine-needle aspiration with an on-site cytopathologist: high accuracy for the diagnosis of mediastinal lymphadenopathy. Chest. 2005;128(4):3004–9.

    Article  PubMed  Google Scholar 

  59. Eloubeidi MA, Cerfolio RJ, Chen VK, Desmond R, Syed S, Ojha B. Endoscopic ultrasound-guided fine needle aspiration of mediastinal lymph node in patients with suspected lung cancer after positron emission tomography and computed tomography scans. Ann Thorac Surg. 2005;79(1):263–8.

    Article  PubMed  Google Scholar 

  60. Micames CG, McCrory DC, Pavey DA, Jowell PS, Gress FG. Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: a systematic review and metaanalysis. Chest. 2007;131(2):539–48.

    Article  PubMed  Google Scholar 

  61. Liberman M, Sampalis J, Duranceau A, Thiffault V, Hadjeres R, Ferraro P. Endosonographic mediastinal lymph node staging of lung cancer. Chest. 2014;146(2):389–97.

    Article  PubMed  Google Scholar 

  62. Wallace MB, Pascual JM, Raimondo M, Woodward TA, McComb BL, Crook JE, et al. Minimally invasive endoscopic staging of suspected lung cancer. JAMA. 2008;299(5):540–6.

    Article  CAS  PubMed  Google Scholar 

  63. Korevaar DA, Crombag LM, Cohen JF, Spijker R, Bossuyt PM, Annema JT. Added value of combined endobronchial and oesophageal endosonography for mediastinal nodal staging in lung cancer: a systematic review and meta-analysis. Lancet Respir Med. 2016;4(12):960–8.

    Article  PubMed  Google Scholar 

  64. Zhang R, Ying K, Shi L, Zhang L, Zhou L. Combined endobronchial and endoscopic ultrasound-guided fine needle aspiration for mediastinal lymph node staging of lung cancer: a meta-analysis. Eur J Cancer. 2013;49(8):1860–7.

    Article  PubMed  Google Scholar 

  65. Oki M, Saka H, Ando M, Kitagawa C, Kogure Y, Seki Y. Endoscopic ultrasound-guided fine needle aspiration and endobronchial ultrasound-guided transbronchial needle aspiration: are two better than one in mediastinal staging of non-small cell lung cancer? J Thorac Cardiovasc Surg. 2014;148(4):1169–77.

    Article  PubMed  Google Scholar 

  66. Herth FJ, Krasnik M, Kahn N, Eberhardt R, Ernst A. Combined endoscopic-endobronchial ultrasound-guided fine-needle aspiration of mediastinal lymph nodes through a single bronchoscope in 150 patients with suspected lung cancer. Chest. 2010;138(4):790–4.

    Article  PubMed  Google Scholar 

  67. Porcel JM, Esquerda A, Vives M, Bielsa S. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol. 2014;50(5):161–5.

    Article  PubMed  Google Scholar 

  68. Kaul V, McCracken DJ, Rahman NM, Epelbaum O. Contemporary approach to the diagnosis of malignant pleural effusion. Ann Am Thorac Soc. 2019;16(9):1099–106.

    Article  PubMed  Google Scholar 

  69. Rooper LM, Ali SZ, Olson MT. A minimum fluid volume of 75 mL is needed to ensure adequacy in a pleural effusion: a retrospective analysis of 2540 cases. Cancer Cytopathol. 2014;122(9):657–65.

    Article  PubMed  Google Scholar 

  70. Obiols C, Call S, Rami-Porta R, Iglesias M, Saumench R, Serra-Mitjans M, et al. Extended cervical mediastinoscopy: mature results of a clinical protocol for staging bronchogenic carcinoma of the left lung. Eur J Cardiothorac Surg. 2012;41(5):1043–6.

    Article  PubMed  Google Scholar 

  71. Witte B, Wolf M, Hillebrand H, Kriegel E, Huertgen M. Extended cervical mediastinoscopy revisited. Eur J Cardiothorac Surg. 2014;45(1):114–9.

    Article  PubMed  Google Scholar 

  72. Lemaire A, Nikolic I, Petersen T, Haney JC, Toloza EM, Harpole DH Jr, et al. Nine-year single center experience with cervical mediastinoscopy: complications and false negative rate. Ann Thorac Surg. 2006;82(4):1185–9; discussion 9–90.

    Article  PubMed  Google Scholar 

  73. Ginsberg RJ, Rice TW, Goldberg M, Waters PF, Schmocker BJ. Extended cervical mediastinoscopy. A single staging procedure for bronchogenic carcinoma of the left upper lobe. J Thorac Cardiovasc Surg. 1987;94(5):673–8.

    Article  CAS  PubMed  Google Scholar 

  74. Metin M, Citak N, Sayar A, Pekcolaklar A, Melek H, Kok A, et al. The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomography reduce the need for invasive procedures? J Thorac Oncol. 2011;6(10):1713–9.

    Article  PubMed  Google Scholar 

  75. Freixinet Gilart J, Garcia PG, de Castro FR, Suarez PR, Rodriguez NS, de Ugarte AV. Extended cervical mediastinoscopy in the staging of bronchogenic carcinoma. Ann Thorac Surg. 2000;70(5):1641–3.

    Article  CAS  PubMed  Google Scholar 

  76. Ernst A, Anantham D, Eberhardt R, Krasnik M, Herth FJ. Diagnosis of mediastinal adenopathy-real-time endobronchial ultrasound guided needle aspiration versus mediastinoscopy. J Thorac Oncol. 2008;3(6):577–82.

    Article  PubMed  Google Scholar 

  77. Um SW, Kim HK, Jung SH, Han J, Lee KJ, Park HY, et al. Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer. J Thorac Oncol. 2015;10(2):331–7.

    Article  PubMed  Google Scholar 

  78. Figueiredo VR, Cardoso PFG, Jacomelli M, Santos LM, Minata M, Terra RM. EBUS-TBNA versus surgical mediastinoscopy for mediastinal lymph node staging in potentially operable non-small cell lung cancer: a systematic review and meta-analysis. J Bras Pneumol. 2020;46(6):e20190221.

    Article  PubMed  Google Scholar 

  79. Visser MPJ, van Grimbergen I, Holters J, Barendregt WB, Vermeer LC, Vreuls W, et al. Performance insights of endobronchial ultrasonography (EBUS) and mediastinoscopy for mediastinal lymph node staging in lung cancer. Lung Cancer. 2021;156:122–8.

    Article  CAS  PubMed  Google Scholar 

  80. Sanz-Santos J, Almagro P, Malik K, Martinez-Camblor P, Caro C, Rami-Porta R. Confirmatory mediastinoscopy after negative endobronchial ultrasound-guided transbronchial needle aspiration for mediastinal staging of lung cancer: systematic review and meta-analysis. Ann Am Thorac Soc. 2022;19(9):1581–90.

    Article  PubMed  Google Scholar 

  81. Martinez-Zayas G, Almeida FA, Simoff MJ, Yarmus L, Molina S, Young B, et al. A prediction model to help with oncologic mediastinal evaluation for radiation: HOMER. Am J Respir Crit Care Med. 2020;201(2):212–23.

    Article  PubMed  PubMed Central  Google Scholar 

  82. O’Connell OJ, Almeida FA, Simoff MJ, Yarmus L, Lazarus R, Young B, et al. A prediction model to help with the assessment of adenopathy in lung cancer: HAL. Am J Respir Crit Care Med. 2017;195(12):1651–60.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Detterbeck FC, Postmus PE, Tanoue LT. The stage classification of lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143(5 Suppl):e191S–210S.

    Article  PubMed  Google Scholar 

  84. Gagliasso M, Migliaretti G, Ardissone F. Assessing the prognostic impact of the International Association for the Study of Lung Cancer proposed definitions of complete, uncertain, and incomplete resection in non-small cell lung cancer surgery. Lung Cancer. 2017;111:124–30.

    Article  PubMed  Google Scholar 

  85. Travis WD, Asamura H, Bankier AA, Beasley MB, Detterbeck F, Flieder DB, et al. The IASLC lung cancer staging project: proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM classification of lung cancer. J Thorac Oncol. 2016;11(8):1204–23.

    Article  PubMed  Google Scholar 

  86. Maeyashiki T, Suzuki K, Hattori A, Matsunaga T, Takamochi K, Oh S. The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer. Eur J Cardiothorac Surg. 2013;43(5):915–8.

    Article  PubMed  Google Scholar 

  87. Cicenia J, Avasarala SK, Gildea TR. Navigational bronchoscopy: a guide through history, current use, and developing technology. J Thorac Dis. 2020;12(6):3263–71.

    Article  PubMed  PubMed Central  Google Scholar 

  88. Tanner NT, Yarmus L, Chen A. Standard bronchoscopy with fluoroscopy vs thin bronchoscopy and radial endobronchial ultrasound for biopsy of pulmonary lesions: a multicenter, prospective, randomized trial. Chest. 2018;154(5):1035–43.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Eberhardt R, Anantham D, Ernst A. Multimodality bronchoscopic diagnosis of peripheral lung lesions: a randomized controlled trial. Am J Respir Crit Care Med. 2007;176(1):36–41.

    Article  PubMed  Google Scholar 

  90. Oki M, Saka H, Ando M. Ultrathin bronchoscopy with multimodal devices for peripheral pulmonary lesions: a randomized trial. Am J Respir Crit Care Med. 2015;192(4):468–76.

    Article  PubMed  Google Scholar 

  91. Folch EE, Pritchett MA, Nead MA, et al. Electromagnetic navigation bronchoscopy for peripheral pulmonary lesions: one-year results of the prospective, multicenter NAVIGATE study. J Thorac Oncol. 2019;14(3):445–58.

    Article  PubMed  Google Scholar 

  92. Chen et al. Chest. 2021;159(2):845–52. https://doi.org/10.1016/j.chest.2020.08.2047. Epub 2020 Aug 19.

  93. Chaddha U, Kovacs SP, Manley C, et al. Robot-assisted bronchoscopy for pulmonary lesion diagnosis: results from the initial multicenter experience. BMC Pulm Med. 2019;19(1):243.

    Google Scholar 

  94. Kalchiem-Dekel O, Connolly JG, Lin IH, et al. Shape-sensing robotic-assisted bronchoscopy in the diagnosis of pulmonary parenchymal lesions. Chest. 2022;161(2):572–82.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pulmonary and Critical Care, Allegheny Health Network, Pittsburgh, PA, USA

    Ghosh Sohini & Marshall Tanya

  2. Department of Pulmonary Disease and Critical Care, Virginia Commonwealth University, Richmond, VA, USA

    Baltaji Stephanie

Authors
  1. Ghosh Sohini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marshall Tanya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Baltaji Stephanie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ghosh Sohini .

Editor information

Editors and Affiliations

  1. Division of Pulmonary Diseases and Critical Care Medicine, University of North Carolina, Chapel Hill, NC, USA

    Christina R. MacRosty

  2. Division of Pulmonary and Critical Care Medicine, University of Rochester Medical Center, Rochester, NY, USA

    M. Patricia Rivera

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Sohini, G., Tanya, M., Stephanie, B. (2023). Staging and Diagnosis of Lung Cancer. In: MacRosty, C.R., Rivera, M.P. (eds) Lung Cancer. Respiratory Medicine. Humana, Cham. https://doi.org/10.1007/978-3-031-38412-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-38412-7_5

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-031-38411-0

  • Online ISBN: 978-3-031-38412-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation